Neuroendocrine neoplasms – still a challenge despite major advances in clinical care with the development of specialized guidelines

Neuroendocrine neoplasms – still a challenge despite major advances in clinical care with the... Reviews in Endocrine and Metabolic Disorders (2017) 18:373–378 https://doi.org/10.1007/s11154-018-9442-7 Neuroendocrine neoplasms – still a challenge despite major advances in clinical care with the development of specialized guidelines 1 2,3,4 Stephan Petersenn & Christian A. Koch Published online: 26 February 2018 Springer Science+Business Media, LLC, part of Springer Nature 2018 The term ‘neuroendocrine neoplasms’ (NEN) covers a wide cardiac and ovarian metastases ([25], bone and lung metasta- range of tumors originating from neuroendocrine cells in var- ses [26], and on peritoneal carcinomatosis [27]. The impor- ious organs. Heterogeneity and rarity of NEN have hampered tance of adequate grading was acknowledged with specific early diagnosis and standardized treatment for years, with guidelines for poorly-differentiated NEN [28, 29], and subse- many physicians being unaware of the clinical relevance of quently with guidelines separately for high-grade neuroendo- NEN. Although expanding knowledge of the molecular char- crine tumors and neuroendocrine carcinomas [30]. To allow acteristics of neuroendocrine cells resulted in new diagnostic for a more standardized approach to NEN, ENETS also pub- and therapeutic possibilities, their integration into manage- lished consensus proposals on the TNM classification of fore- ment algorithms is still ongoing. Furthermore, availability of gut [31] and midgut/hindgut NEN [32]. In addition, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reviews in Endocrine and Metabolic Disorders Springer Journals

Neuroendocrine neoplasms – still a challenge despite major advances in clinical care with the development of specialized guidelines

Loading next page...
 
/lp/springer_journal/neuroendocrine-neoplasms-still-a-challenge-despite-major-advances-in-7iOpT0cIba
Publisher
Springer US
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Endocrinology; Diabetes; Internal Medicine
ISSN
1389-9155
eISSN
1573-2606
D.O.I.
10.1007/s11154-018-9442-7
Publisher site
See Article on Publisher Site

Abstract

Reviews in Endocrine and Metabolic Disorders (2017) 18:373–378 https://doi.org/10.1007/s11154-018-9442-7 Neuroendocrine neoplasms – still a challenge despite major advances in clinical care with the development of specialized guidelines 1 2,3,4 Stephan Petersenn & Christian A. Koch Published online: 26 February 2018 Springer Science+Business Media, LLC, part of Springer Nature 2018 The term ‘neuroendocrine neoplasms’ (NEN) covers a wide cardiac and ovarian metastases ([25], bone and lung metasta- range of tumors originating from neuroendocrine cells in var- ses [26], and on peritoneal carcinomatosis [27]. The impor- ious organs. Heterogeneity and rarity of NEN have hampered tance of adequate grading was acknowledged with specific early diagnosis and standardized treatment for years, with guidelines for poorly-differentiated NEN [28, 29], and subse- many physicians being unaware of the clinical relevance of quently with guidelines separately for high-grade neuroendo- NEN. Although expanding knowledge of the molecular char- crine tumors and neuroendocrine carcinomas [30]. To allow acteristics of neuroendocrine cells resulted in new diagnostic for a more standardized approach to NEN, ENETS also pub- and therapeutic possibilities, their integration into manage- lished consensus proposals on the TNM classification of fore- ment algorithms is still ongoing. Furthermore, availability of gut [31] and midgut/hindgut NEN [32]. In addition,

Journal

Reviews in Endocrine and Metabolic DisordersSpringer Journals

Published: Feb 26, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial